- Investing Ideas
- /
- German Undervalued Stocks Based On Cash Flows
German Undervalued Stocks Based On Cash Flows
Results
22
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
22 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
TTR1 | €16.20 | 11.7% | -19.0% | €111.9m | €22.00 | PE14.8x | E25.0% | 3.8% | Capital Goods | ||
MTX | €267.40 | 3.4% | 31.7% | €14.4b | €267.14 | PS2.5x | E34.1% | 0.7% | Capital Goods | ||
BDT | €23.90 | -2.4% | -45.9% | €241.5m | €37.00 | PE14.2x | E60.1% | 5.0% | Commercial Services | ||
VBK | €17.12 | 6.3% | -58.4% | €1.1b | €30.85 | PE56.7x | E68.7% | 1.2% | Energy | ||
R3NK | €24.96 | -0.8% | n/a | €2.6b | €32.00 | PE79.2x | E34.4% | 1.2% | Capital Goods | ||
HNL | €16.80 | 5.7% | -20.0% | €101.8m | €22.75 | PS1x | E119.1% | n/a | Capital Goods | ||
PBB | €4.89 | -2.3% | -31.6% | €657.0m | €6.36 | PE16.8x | E41.8% | n/a | Diversified Financials | ||
M12 | €14.50 | 6.2% | 96.5% | €265.6m | €27.50 | PE25.8x | E24.4% | 3.4% | Healthcare | ||
E4C | €13.60 | 7.1% | -22.1% | €47.7m | €38.70 | PE32.9x | E49.6% | 3.5% | Telecom | ||
V3S | €11.15 | 3.2% | 110.4% | €89.8m | €10.25 | PS2.4x | E118.7% | 0% | Tech | ||
LPK | €8.45 | 1.7% | 9.5% | €206.8m | €12.05 | PE87.9x | E69.9% | n/a | Tech | ||
SAP | €195.98 | 4.1% | 58.2% | €228.6b | €209.52 | PE89.3x | E37.9% | 1.1% | Software | ||
BSL | €10.12 | 3.8% | -26.5% | €311.1m | €15.40 | PS1.7x | E98.9% | 0% | Tech | ||
IXX | €38.50 | 0.5% | 31.4% | €378.9m | €52.25 | PE20.3x | E21.6% | 1.8% | Software | ||
ADS | €218.40 | 1.3% | 18.1% | €39.0b | €237.77 | PE199x | E40.7% | 0.3% | Consumer Durables | ||
MBB | €101.80 | 4.4% | 33.4% | €581.9m | €123.00 | PE31.4x | E44.0% | 1.0% | Capital Goods | ||
EQS | €39.40 | 0% | 90.3% | €394.9m | €37.50 | PS5.5x | E115.5% | 0% | Software | ||
SJJ | €13.20 | 2.3% | 57.1% | €138.6m | €20.50 | PS1.4x | E114.4% | 0% | Software | ||
S9I | €48.30 | 0.2% | 50.9% | €314.0m | €45.75 | PE26.1x | E23.2% | 2.1% | Tech | ||
FYB | €51.20 | 5.5% | -18.6% | €904.2m | €86.33 | PE14.2x | E31.3% | n/a | Pharmaceuticals & Biotech | ||
CEK | €4.92 | -3.5% | 40.6% | €39.9m | €8.11 | PS1.5x | E48.7% | 3.0% | Tech | ||
SUSE | €10.89 | -0.2% | -41.9% | €1.9b | €14.44 | PS3x | E117.7% | 28.4% | Software |
Page 1 of 1